Nuvation Bio股价上涨，脑癌药物数据推动研究范围扩大

路透中文07-20
BUZZ-<a href="https://laohu8.com/S/NUVB">Nuvation Bio</a>股价上涨，脑癌药物数据推动研究范围扩大

7月20日 - ** 癌症治疗公司Nuvation Bio（NUVB.N）股价上涨5.3%，至6.11美元

** 该公司表示，其实验性脑癌药物萨福西尼布（safusidenib） 在IDH1突变型胶质瘤患者中显示出 52%的确证应答率，该病症是一种由基因突变引起的常见脑肿瘤

** 据称，在日本开展的一项中期研究中，近80%的患者在开始治疗三年后仍存活且病情未恶化

** 公司将在美国境外启动一项晚期临床试验，入组约140名未接受过化疗或放疗的新确诊患者

** 称萨福西尼布的安全性特征仍处于可控范围

** 计入本次交易后，该股今年以来累计跌幅约为32%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment